DONOR-SPECIFIC HYPOREACTIVITY AFTER LIVER-TRANSPLANTATION - PROMINENTDECREASES IN DONOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTE PRECURSOR FREQUENCIES INDEPENDENT OF CHANGES IN HELPER T-LYMPHOCYTE PRECURSOR FREQUENCIES OR SUPPRESSOR-CELL ACTIVITY
A. Dehaan et al., DONOR-SPECIFIC HYPOREACTIVITY AFTER LIVER-TRANSPLANTATION - PROMINENTDECREASES IN DONOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTE PRECURSOR FREQUENCIES INDEPENDENT OF CHANGES IN HELPER T-LYMPHOCYTE PRECURSOR FREQUENCIES OR SUPPRESSOR-CELL ACTIVITY, Transplantation, 66(4), 1998, pp. 516-522
Background. The development of immunological donor-specific hyporeacti
vity may account for the low incidence of chronic rejection after clin
ical liver transplantation. We investigated whether hyporeactivity com
monly develops after liver transplantation by analyzing precursor freq
uencies of donor-reactive cytotoxic (CTLp) and helper (HTLp) T lymphoc
ytes and mixed lymphocyte culture (MLC) reactivity in liver allograft
recipients. We further studied whether CTLp hyporeactivity correlated
with changes in donor-specific HTLp frequencies or suppressor cell act
ivity. Methods. CTLp and HTLp frequencies and MLC reactivity against d
onor and third-party spleen cells were determined in pre- and posttran
splantation peripheral blood samples from 18 recipients with good graf
t function 2 years after transplantation. By mixing posttransplantatio
n samples (with ''putative'' suppressor cell activity) with pretranspl
antation samples tin which normal CTL activity with no suppressor cell
activity is expected), the presence of suppressor cell activity in pe
ripheral blood was analyzed. Results. Two years after transplantation,
all but one (94%) of the recipients had developed CTLp hyporeactivity
as evidenced by reduced donor-specific CTLp frequencies. The developm
ent of hyporeactivity was not specific for any particular underlying d
isease. The occurrence of HTL hyporeactivity, however, was less freque
nt: 38% and 20% of recipients were HTLp and MLC hyporeactive, respecti
vely. Decreases in CTLp frequencies did not correlate with decreased d
onor-specific HTL function or suppressor cell activity in peripheral b
lood samples. Conclusions. Donor-specific CTLp hyporeactivity can deve
lop in the majority of liver allograft recipients, irrespective of und
erlying disease. Donor-specific HTL hyporeactivity, however, occurs in
frequently. A reduction in donor-specific CTLp frequencies was found t
o be independent of changes in donor-specific HTLp or suppressor cell
activity, suggesting that other mechanisms (e.g., clonal deletion) are
operative in the reduction of donor-specific CTLp after liver transpl
antation.